Skip to content
Review Open access

EARLY INTRAVENOUS DIURETIC ADMINISTRATION AND MORTALITY IN ACUTE HEART FAILURE: A SYSTEMATIC REVIEW AND DOSE-RESPONSE META-ANALYSIS

Oct 2026 · European Heart Journal, Supplement · 0 citations

TL;DR

The observed dose-response relationship supports consideration of D2D time as a potential systems-level quality metric, warranting prospective validation, and suggests amplification of the survival gradient in registries with higher baseline mortality rates.

Abstract

In acute coronary syndromes, “time is muscle.” In acute heart failure (AHF), time-sensitive decongestion may similarly influence outcomes. The door-to-diuretic (D2D) interval represents a potentially modifiable systems-level intervention analogous to door-to-balloon time. We evaluated the association between D2D time and short-term mortality using a dose-response meta-analytic approach. We conducted a systematic review and dose-response meta-analysis of major AHF registries (REALITY-AHF, REPORT-HF, GREAT, K-CHF), comprising 28,124 patients. Adjusted odds ratios (aOR) for in-hospital mortality and adjusted hazard ratios (aHR) for 30-day mortality were analyzed separately. Random-effects models with Knapp-Hartung adjustment were applied. Dose-response relationships were modeled using generalized least squares for trend (GLST), anchored at a clinically defined ≤60-minute reference threshold. Early intravenous diuretic administration (≤60 minutes) was associated with lower 30-day mortality (pooled aHR 0.77, 95% CI 0.64–0.93; I²=58%). In-hospital mortality demonstrated substantial heterogeneity (I²=72%); while the REALITY-AHF registry showed a strong association (aOR 0.39, 95% CI 0.20–0.76), the pooled estimate showed a non-significant trend (pooled aOR 0.84, 95% CI 0.57–1.24). Dose-response modeling revealed a linear increase in mortality risk for every 30-minute delay beyond the first hour. Meta-regression suggested amplification of the survival gradient in registries with higher baseline mortality rates. Earlier intravenous diuretic administration was associated with improved 30-day survival in AHF. Although residual confounding cannot be excluded, the observed dose-response relationship supports consideration of D2D time as a potential systems-level quality metric, warranting prospective validation.Figure 1.Dual-Panel Forest Plot of the Association Between Door-to-Diuretic Time and Short-Term Mortality in Acute Heart Failure. Panel A shows adjusted odds ratios (aOR) for in-hospital mortality comparing early (≤60 minutes) versus delayed (>60 minutes) intravenous diuretic administration. The pooled estimate using a random-effects model with Knapp–Hartung adjustment demonstrated a non-significant association (aOR 0.84, 95% CI 0.57–1.23; I² = 72%). Panel B displays adjusted hazard ratios (aHR) for 30-day mortality. Early diuretic administration was associated with significantly lower 30-day mortality (pooled aHR 0.77, 95% CI 0.64–0.93; I² = 58%). Squares represent study-specific effect estimates weighted by inverse variance, and diamonds indicate pooled random-effects estimates. Vertical lines denote 95% confidence intervals, and the reference line corresponds to an effect size of 1.0.

Read PDF

Similar papers

Review Open access Oct 2026

Short-term decongestion and clinical benefit in acute heart failure: a systematic review and trial-level meta-regression

The randomized trial-level evidence evaluated here is insufficient to validate short-term weight change as a surrogate for post-discharge clinical outcomes in AHF and showed a directional but non-robust trial-level association with clinical benefit.

Hui-Ming Wang, Hang Fang, Meng-Qi Wu et al. · 0 citations
Open access Sep 2026

Timing of Loop Diuretic Initiation for De-Resuscitation in Sepsis-Associated Acute Kidney Injury: A Landmark Analysis with External Validation.

BackgroundPositive fluid balance is associated with worse outcomes in sepsis-associated acute kidney injury (SA-AKI), but the optimal timing for active fluid removal (de-resuscitation) is unknown. We examined whether earlier loop-diuretic therapy is associated with lower mortality than later initiation.MethodsUsing MIM...

Lu-Jun Shao, Yue Li, Cheng Xu et al. · 0 citations
Open access Oct 2026

Hyperkalemia and its outcome implications in patients with heart failure with reduced ejection fraction: results from a single-center cohort

In this contemporary real-world cohort of patients with HFrEF, HK was frequent but predominantly mild, and the target of minimizing GDMT was achieved, with this approach the occurrence of HK in this cohort was not associated with a higher risk of adverse clinical outcomes.

M. Mantovani, N. Bonini, M. Vitolo et al. · 0 citations
Open access Nov 2026

Dapagliflozin vs. Acetazolamide in Patients With Acute Heart Failure: A Randomized Controlled Trial (CHOICE-AHF).

Early adjunctive therapies may improve decongestion and symptoms in acute heart failure. This trial compared dapagliflozin with acetazolamide when initiated early, focusing on dyspnea relief as the primary outcome and decongestive, diuretic, natriuretic, and safety outcomes. In this randomized, active-controlled trial,...

Hossam Sharaf, M. Wadie, N. O. Mansour et al. · 0 citations
Open access Sep 2026

Decisions in Diuretic Resistance: Oral or Subcutaneous Furosemide in Advanced Ambulatory Heart Failure?

In this exploratory real-world cohort of patients with advanced HF and refractory congestion, both outpatient furosemide strategies were associated with short-term decongestion, with differences observed in symptomatic response.

R. López-Vilella, Borja Guerrero Cervera, Emilio Monte Boquet et al. · 0 citations
Open access Oct 2026

Beta-blockers after acute coronary syndrome: insights across the ejection fraction spectrum.

Aims To evaluate the association between beta-blocker (BB) prescription and long-term all-cause mortality after acute coronary syndrome (ACS), and to assess whether this varies across the left ventricular ejection fraction (LVEF) spectrum. Methods and results We analysed ACS patients from the retrospective multicentr...

E. Tsiartas, Sokratis Oikonomou, A. Iordanidou et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.